Application: Research peptide evaluated in healing, anti-inflamation, gastrointestinal health, neurology, cancer, cosmetics, organ protection, MS, and longevity
Chemical Formula: C62H98N16O22 (BPC-157) + C212H350N56O78S (TB-500)
CAS Number: BPC-157 137525-51-0, TB-500 77591-33-4
Molecular Weight: BPC-157: ~1419.5 g/mol, TB-500: ~4963 g/mol
Concentration: ≥99%
The combination of BPC-157 and TB-500 peptides represents an emerging area of research in regenerative medicine. While both peptides have been studied individually, their combined therapeutic potential may multiply on mechanism and effect.
Primary Research Areas
1. Wound Healing and Tissue Regeneration
The BPC-157+TB-500 combination is being investigated for its potential to:
- Accelerate wound healing processes
- Enhance tissue regeneration capabilities
- Promote collagen synthesis
2. Musculoskeletal Applications
Research is focused on the combination's ability to treat:
- Tendon injuries and damage
- Ligament repairs
- Muscle tissue regeneration
Through mechanisms of: - Cell proliferation
- Cell differentiation
- Enhanced cell migration
3. Gastrointestinal Health
Studies are exploring the peptide combination's therapeutic potential for:
- Ulcerative colitis treatment
- Colon cancer applications
- General gastrointestinal repair
4. Neurological Applications
Researchers are investigating the combination for:
- Neuroprotective properties
- Potential treatment of multiple sclerosis
- General neuroregeneration capabilities
5. Organ Protection
Current research examines protective effects on:
- Liver tissue
- Kidney function
- Lung tissue integrity
Research Status
It's important to note that while individual components (BPC-157 and TB-500) have been extensively studied, research on their combination is relatively new. The scientific community continues to investigate:
- Optimal dosing protocols
- Synergistic effects
- Safety profiles
- Long-term outcomes
Mechanism of Action
The combination is being studied for its dual mechanisms:
- BPC-157's targeted healing properties and angiogenic effects
- TB-500's systemic healing and anti-inflammatory properties
References:
Vukojevic, J., Milavić, M., Perović, D., Ilić, S., Čefarin, D., Nikolić, M., Đurašević, S., Mitić, D., Matić, A., & Sikiric, P. (2022). Pentadecapeptide BPC 157 and the central nervous system. Neural Regeneration Research, 17(3), 482-487. https://doi.org/10.4103/1673-5374.320969
Seiwerth, S., Rucman, R., Turkovic, B., Sever, M., Klicek, R., Radic, B., Drmic, D., Stupnisek, M., Misic, M., Vuletic, L. B., Pavlov, K. H., Barisic, I., Kokot, A., Japjec, M., Blagaic, A. B., Tvrdeic, A., Rokotov, D. S., Vrcic, H., Staresinic, M., & Sikiric, P. (2018). BPC 157 and standard angiogenic growth factors: Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Current Pharmaceutical Design, 24(18), 1972-1989. https://doi.org/10.2174/1381612824666180712110447
Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L. B., Drmic, D., Grgic, T., Strbe, S., Zukanovic, G., Crvenkovic, D., Madzarac, G., Rukavina, I., Sucic, M., Baric, M., Starcevic, N., Krstonijevic, Z., Bencic, M. L., Filipcic, I., Rokotov, D. S., & Vlainic, J. (2016). Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications. Current Neuropharmacology, 14(8), 857-865. https://doi.org/10.2174/1570159X14666160502153022
Disclaimer: This product is intended solely for laboratory research purposes. It is not suitable for consumption by humans, nor for medical, veterinary, or household purposes. Researchers should handle all peptides with care and adhere to strict safety guidelines during experiments. Only qualified professionals with appropriate expertise should manage and handle this product. The distributor, manufacturer, and seller of this product are not responsible for misuse or any resulting consequences. By accessing this product, you consent to comply with these terms and conditions.
